Duration and association with protection of NANP-repeat-specific and C-terminus-specific anti-circumsporozoite protein IgG responses following RTS,S/AS01E vaccination: an observational ancillary immunological study of a phase 3 clinical trial.
Lara-Escandell M, Sánchez L, Macià D, Jairoce C, Mpina M, Sorgho H, Agnandji ST, Dosoo D, Gyan B, Vidal M, Jiménez A, Mitchell RA, Medina-Expósito D, Puyol L, Santano R, Dutta S, Owusu-Agyei S, Asante KP, Tinto H, Aide P, Nhabomba A, Mordmüeller B, Daubenberger C, Aguilar R, Waitumbi J, Moncunill G, Dobaño C.
Lara-Escandell M, et al. Among authors: agnandji st.
Lancet Infect Dis. 2026 Aug;26(8):832-842. doi: 10.1016/S1473-3099(26)00081-2. Epub 2026 Apr 21.
Lancet Infect Dis. 2026.
PMID: 42030969
Free PMC article.
Clinical Trial.